Fri, Feb 27, 2015, 7:44 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Boston Scientific Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • politicaldebate1 politicaldebate1 Aug 14, 2005 10:19 PM Flag

    Next stop $21. Down she goes

    (All investors want their stocks to turn out winners. So if a stock you buy heads south, you might hang on in hopes of a reversal. It's been a longtime leader and will come back, you reason. But if a turnaround never occurs, such hopes can erode your gains or even seriously damage your portfolio.

    That's why sell rules are just as important as buy rules. Always pay attention to warning signs, and cut your losses if a stock falls 7% to 8% below your initial buy price. Don't let hope tarnish that golden rule.

    If you don't contain a loss while it's small, it could quickly snowball into 20% or more. Your best tactic is to cut your losses and move onto another stock

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • How much is this costing?? How long can they keep losing money?
      Natick, MA (June 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a jury in a patent infringement case in U.S. District Court in Delaware brought by Johnson & Johnson (NYSE: JNJ) against Boston Scientific has returned a verdict. The jury found that Boston Scientific's stents infringe a J&J patent and that the Libert� stent infringes a second J&J patent. Boston Scientific had challenged the validity of one of the patents, and the jury upheld the patent's validity. The jury only determined liability; monetary damages will be determined in a later trial.Bostin Scientific stated that it is disappointed in the jury's decision.

      Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a civil settlement agreement with the U.S. Department of Justice regarding the Department's investigation. The Company agreed to pay $74 million as part of the agreement. (OUCH)

      Boston Scientific Announces Worldwide Recall of Hemashield� VANTAGE� Peripheral Vascular Grafts.

      Natick, MA (June 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling worldwide all Hemashield� VANTAGE� Vascular Grafts, which are used in peripheral procedures. No other Hemashield� products are affected by this recall. The Company is recalling all Hemashield VANTAGE Vascular Grafts manufactured in the last two years due to the potential of the device to fray or tear during suturing and the possibility that it could lead to post-operative complications. The Company is aware of three reported post-operative failures which occurred between three and seven days post-procedure

      • 6 Replies to trolltrader2
      • Insider selling and debt increasing along with the falling chart tells the story of a forthcoming crash at BSX.

      • Uh oh more bad news...
        Doctors have continued reporting injuries during the implantation of cardiac stents made by Boston Scientific Corp., many of them linked to a problem that preceded a voluntary temporary recall of the devices last year.

        Balloons used to deploy the stents -- small, wire-mesh tubes inserted into clogged arteries to open them up -- failed to deflate or were so hard to remove that three people died and dozens more were injured during operations performed after the 2004 recall, according to Food and Drug Administration records.

        A review of the FDA data shows that between last Oct. 1 and April 1, the agency received at least 45 reports of deflation difficulties with Boston Scientific stent balloons. In 86 other cases, doctors reported that the balloons became stuck or otherwise were difficult to withdraw from a patient's body.

        The problems leading to injuries were detailed in "adverse event" reports submitted to the FDA voluntarily by doctors. In most cases, those reports came through the company, as often happens.


        How much are these lawsuits gonna cost?

        Problems With Boston Scientific Heart Stent Persisted After Even After Recall, Report Says

        NATICK, Mass. (AP) -- Doctors continued reporting surgical problems with a heart stent made by Boston Scientific Corp. even after the company recalled nearly 100,000 of the devices and fixed a manufacturing flaw, according to a published report.

        Tiny balloons used to insert the stents into coronary arteries failed to deflate or were so difficult to remove that numerous people died and dozens more were injured during surgeries after last year's recall, The Wall Street Journal reported Wednesday, citing U.S. Food and

      • Uh oh more bad news...
        Doctors have continued reporting injuries during the implantation of cardiac stents made by Boston Scientific Corp., many of them linked to a problem that preceded a voluntary temporary recall of the devices last year.

        Balloons used to deploy the stents -- small, wire-mesh tubes inserted into clogged arteries to open them up -- failed to deflate or were so hard to remove that three people died and dozens more were injured during operations performed after the 2004 recall, according to Food and Drug Administration records.

        A review of the FDA data shows that between last Oct. 1 and April 1, the agency received at least 45 reports of deflation difficulties with Boston Scientific stent balloons. In 86 other cases, doctors reported that the balloons became stuck or otherwise were difficult to withdraw from a patient's body.

        The problems leading to injuries were detailed in "adverse event" reports submitted to the FDA voluntarily by doctors. In most cases, those reports came through the company, as often happens.

      • Doctors have continued reporting injuries during the implantation of cardiac stents made by Boston Scientific Corp., many of them linked to a problem that preceded a voluntary temporary recall of the devices last year.

        Balloons used to deploy the stents -- small, wire-mesh tubes inserted into clogged arteries to open them up -- failed to deflate or were so hard to remove that three people died and dozens more were injured during operations performed after the 2004 recall, according to Food and Drug Administration records.

        A review of the FDA data shows that between last Oct. 1 and April 1, the agency received at least 45 reports of deflation difficulties with Boston Scientific stent balloons. In 86 other cases, doctors reported that the balloons became stuck or otherwise were difficult to withdraw from a patient's body.

        The problems leading to injuries were detailed in "adverse event" reports submitted to the FDA voluntarily by doctors. In most cases, those reports came through the company, as often happens.


        How much are these lawsuits gonna cost?

      • More BS from yet another shorty puke.

        Is that all you idiots can do, cut and past old news? Get a life. Get a job (a real, productive one).

      • View More Messages
    • Makes no sense to sell a stock at it's bottom, which is driven only by potential negative legal results; if any of these go positive, UP SHE GOES...

 
BSX
16.90+0.08(+0.48%)Feb 27 4:04 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.